KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Edwards Lifesciences (EW) over the last 9 years, with Q3 2025 value amounting to $38.6 million.

  • Edwards Lifesciences' Interest & Investment Income rose 5884.77% to $38.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.5 million, marking a year-over-year increase of 13851.35%. This contributed to the annual value of $120.3 million for FY2024, which is 7901.79% up from last year.
  • According to the latest figures from Q3 2025, Edwards Lifesciences' Interest & Investment Income is $38.6 million, which was up 5884.77% from $37.4 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Interest & Investment Income ranged from a high of $64.0 million in Q4 2024 and a low of $15.5 million during Q2 2024